Technical writing on peptide chemistry, analytical methodology and documentation. Structure, mechanism and method — no outcome claims, no protocols, no use guidance.
Why a sterile material can still carry endotoxin, how the limulus amebocyte lysate assay works, what recombinant Factor C changed, and how to read an endotoxin result on a certificate of analysis.
Read →The chemistry that starts when a lyophilised peptide meets solvent: hydrolysis, deamidation, oxidation and aggregation, why pH governs the rate, and what a bacteriostatic preservative does and does not protect against.
Read →Freeze-drying explained: sublimation and desorption, why removing water removes the reagent that degrades peptides, what the cake tells you about the cycle, and why appearance is a release assay rather than cosmetics.
Read →Gross mass, net peptide content and the counterion problem: what else is on the balance when a synthetic peptide is weighed out, why trifluoroacetate is there, and how the actual peptide quantity is determined.
Read →How electrospray ionisation, charge-state deconvolution and peptide mapping establish which compound is in a vial — and why a matching molecular weight is necessary but not sufficient.
Read →What a purity percentage on a certificate of analysis actually represents: area normalisation by reversed-phase HPLC, why detection wavelength changes the figure, and the three questions purity cannot answer.
Read →RUO is a real regulatory category with real limits, not a disclaimer bolted onto a product page. What the designation covers, what it does not, and what it means for how material is supplied.
Read →CAS registry numbers identify defined substances, not mixtures. What that means for specifying multi-peptide blends correctly — and what a single CAS on a blend listing tells you about the supplier.
Read →Why lyophilized peptides are stable and solutions are not — hydrolysis, oxidation, adsorption and freeze-thaw, and what actually degrades a research peptide in the lab.
Read →A structural comparison of BPC-157 and TB-500 — sequence origin, molecular weight, CAS registry numbers, and why they are studied on different pathways despite being sold together.
Read →A structural and receptor-target comparison of three incretin research peptides — GLP-1, GIP and glucagon receptor engagement, molecular weights, CAS numbers and what the acylation is doing.
Read →What HPLC, mass spectrometry and endotoxin figures on a peptide COA actually establish — and the common ways a certificate can look reassuring while proving very little.
Read →